Skip to content
HowShorted

Acadia Healthcare Company, Inc. short interest in 2022

In 2022, Acadia Healthcare Company, Inc.'s disclosed short interest ran from 3.11% of shares outstanding on 14 Jan 2022 to 3.70% on 30 Dec 2022, a change of +0.59 percentage points. The year's high was 4.96% on 14 Oct 2022 and its low 3.09% on 31 Mar 2022, averaging 3.94% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.67 days on 14 Oct 2022. Full history: Acadia Healthcare Company, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Acadia Healthcare Company, Inc. in 2022

2022 in figures

Start of year
3.11% (14 Jan 2022)
End of year
3.70% (30 Dec 2022)
Change
+0.59 pp
High
4.96% (14 Oct 2022)
Low
3.09% (31 Mar 2022)
Average
3.94%
Highest days to cover
9.67 (14 Oct 2022)
SEC filings marked
8

Every report in 2022

Acadia Healthcare Company, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20223.11%4.87
31 Jan 20223.32%7.49
15 Feb 20223.67%8.22
28 Feb 20223.80%8.39results (8-K)
15 Mar 20223.62%5.3710-K filed
31 Mar 20223.09%4.93
14 Apr 20223.37%3.38
29 Apr 20224.00%4.90
13 May 20224.16%4.78results (8-K), 10-Q filed
31 May 20223.91%7.81
15 Jun 20224.04%9.14
30 Jun 20223.74%5.97
15 Jul 20223.79%6.27
29 Jul 20223.90%4.47results (8-K), 10-Q filed
15 Aug 20224.02%8.16
31 Aug 20224.53%6.76
15 Sep 20224.67%7.83
30 Sep 20224.77%6.59
14 Oct 20224.96%9.67
31 Oct 20224.59%5.75results (8-K)
15 Nov 20224.08%5.2210-Q filed
30 Nov 20223.99%6.43
15 Dec 20223.79%4.83
30 Dec 20223.70%6.44

See also: Acadia Healthcare Company, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.